Medtronic has received European CE Mark of approval to market the transcatheter CoreValve system now with the AccuTrak Stability Layer for replacing aortic valves. The AccuTrak system purportedly provides greater control and usability for surgeons deploying the valves.
AccuTrak’s proprietary technology allows physicians to achieve enhanced control and accuracy in the deployment of the CoreValve device.¹ This next generation technology builds upon the CoreValve system that first received CE (Conformité Européenne) Mark in March 2007. CoreValve and AccuTrak are not yet available in the United States, Canada or Japan for investigational or commercial sale or use.
“The AccuTrak stability layer is a valuable advancement for CoreValve, which already offers a unique self-expanding design to control the positioning and release of the valve,” said Prof. Rüdiger Lange, M.D., Ph.D., director of cardiovascular surgery at The German Heart Centre in Munich, Germany, whose center was among the first to use the new delivery system with the AccuTrak StabilityLayer in a CoreValve implantation. “This system makes it easier to precisely position the CoreValve device, which can be important to achieving positive procedure outcomes. The increased accuracy and control with the new delivery system may also make it even easier to train physicians to perform TAVI procedures.”
Press release: Medtronic Gains CE Mark for Enhanced CoreValve® Delivery Catheter System with AccuTrak Stability Layer…
Product page: CoreValve…
Flashbacks: Flashbacks: Edwards Sapien Transcatheter Aortic Valve Makes Human Debut; Minimally Invasive Aortic Valve Replacement With the Lotus System; Edwards Lifesciences Delays Cribier-Edwards Percutaneous Aortic Valve Trials; Edwards Sapien Transcatheter Aortic Valve Makes Human Debut; Minimally Invasive Aortic Valve Replacement With the Lotus System; Edwards Lifesciences Delays Cribier-Edwards Percutaneous Aortic Valve Trials